Sun Pharmaceutical Industries Ltd receives warning letter for Halol facility

Sun Pharmaceutical Industries Limited had earlier announced regarding the USFDA inspection at the Company's Halol (Gujarat, India) facility from April 26 to May 9, 2022.

The Company has received Warning Letter from USFDA for the Halol facility. The Warning Letter summarizes violations with respect to Current Good Manufacturing Practice (cGMP) regulations. USFDA shall make public the contents of the Warning Letter in due course.

As per the communication dated December 08, 2022, the Halol facility was placed under Import Alert by USFDA.

Shares of Sun Pharmaceutical Industries Limited was last trading in BSE at Rs. 993.25 as compared to the previous close of Rs. 1001.55. The total number of shares traded during the day was 18545 in over 1500 trades.

The stock hit an intraday high of Rs. 1005.10 and intraday low of 987.80. The net turnover during the day was Rs. 18485702.00.

Source : Equity Bulls

Keywords

SunPharmaceuticalIndustries INE044A01036 WarningLetter HalolFacility